ALBANY MOLECULAR RESEARCH, INC. Toevoegen aan een lijst
Inactief instrument
Onderneming Albany Molecular Research, Inc.
Aandelen
US0124231095
Biotechnologie & Medisch Onderzoek
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Philip W Macnabb
CEO | Chief Executive Officer | - | 01-05-23 |
Meera Khullar
CMP | Compliance Officer | - | 01-03-19 |
Prakash Pandian
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-18 |
| Chief Tech/Sci/R&D Officer | - | 01-10-19 | |
Javier Gallo
PRN | Corporate Officer/Principal | - | - |
Scott Wagner
PRN | Corporate Officer/Principal | - | 01-01-19 |
| Human Resources Officer | - | 01-10-17 | |
Stacie Phillips
LAW | General Counsel | 50 | 01-08-18 |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | - |
Sean Cunningham
BRD | Director/Board Member | 48 | - |
William McMullan
BRD | Director/Board Member | 46 | - |
Maria Hilado
BRD | Director/Board Member | 59 | 01-09-21 |
| Director/Board Member | 46 | - |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 48 631 283 | 30 278 873 ( 62,26 %) | 5 512 000 ( 11,33 %) | 62,26 % |
Bedrijfsgegevens
Sector
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +19,41% | 45,51 mld. | |
| -8,62% | 38,52 mld. | |
| +38,65% | 38,13 mld. | |
| +26,95% | 30,74 mld. | |
| -13,50% | 26,03 mld. | |
| +10,74% | 25,92 mld. | |
| +44,87% | 14,13 mld. | |
| +34,36% | 12,73 mld. | |
| -7,14% | 11,29 mld. |
